Safety and Efficacy Study of Sintilimab Combined With IBI305 in Patients With Advanced Hepatocellular Carcinoma
Clinical trial NCT04072679 · COMPLETED
Trial details
- NCT number
- NCT04072679
- Sponsor
- Chinese Academy of Medical Sciences
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-11
- Primary completion
- 2020-03-31
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.